SABCS

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer

December 25th 2025, 4:00pm

Article

BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, HER2-negative breast cancer is safe.

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

December 23rd 2025, 8:00pm

Article

At the 2025 SABCS, researchers presented findings with the potential to meaningfully affect breast cancer treatment and patient care.

Enhertu Improves Survival Over Kadcyla In Early Stage HER2+ Breast Cancer

December 22nd 2025, 8:00pm

Article

DESTINY-Breast05 analyses show post neoadjuvant Enhertu improves invasive disease free survival compared with Kadcyla in patients with residual early stage breast cancer.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025, 10:06pm

Article

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

December 12th 2025, 10:01pm

Article

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025, 6:11pm

Article

Hormone therapy after breast cancer did not increase risk in BRCA1/2 carriers; estrogen alone was linked to lower risk.

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

December 12th 2025, 5:10pm

Article

For AYA breast cancer survivors, mobile health intervention was associated with improvements to general and cancer-specific quality of life.

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

December 12th 2025, 4:07pm

Article

Real and sham acupuncture improved perceived cognitive function versus usual care, with real acupuncture showing greater benefits for objective cognitive outcomes.

Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

December 11th 2025, 6:46pm

Article

The 60-month local regional recurrence-free rate was 93.2% in the MRI arm versus 95.7% in the no MRI arm, researchers reported.

Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

December 11th 2025, 5:51pm

Article

Enhertu and Perjeta led to better quality-of-life and less side effects than standard-of-care among patients with HER2+ advanced or metastatic breast.